Akebia Therapeutics, Inc.
← Back to AKBA Overview

Akebia Therapeutics, Inc. (AKBA)

Revenue & Top-Line Growth

Latest Revenue

$53.5M

Financial Fundamentals

AKBAQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-03-310.05B-7.1%-6.6%0.23B+25.7%
2025-12-310.06B-2.0%+23.9%0.24B+47.5%
2025-09-300.06B-5.9%+57.0%0.23B+32.5%
2025-06-300.06B+9.0%+43.1%0.20B+16.8%
2025-03-310.06B+23.3%+75.8%0.18B-1.2%
2024-12-310.05B+24.2%-17.3%0.16B-17.7%
2024-09-300.04B-14.3%-11.0%0.17B-12.3%
2024-06-300.04B+33.9%-22.6%0.17B-12.9%
2024-03-310.03B-42.0%-18.5%0.19B-30.7%
2023-12-310.06B+33.7%+1.8%0.19B-33.3%
2023-09-300.04B-25.4%-13.7%0.19B-34.2%
2023-06-300.06B+40.9%-55.4%0.20B-32.0%
2023-03-310.04B-27.5%-35.2%0.27B+22.3%
2022-12-310.06B+13.3%-4.3%0.29B+37.9%
2022-09-300.05B-61.4%-0.1%0.29B+39.8%
2022-06-300.13B+104.8%+138.8%0.29B+32.7%
2022-03-310.06B+7.0%+18.0%0.22B-14.7%
2021-12-310.06B+18.3%+1.7%0.21B-28.3%
2021-09-300.05B-7.9%-18.7%0.21B-31.6%
2021-06-300.05B+1.2%-41.3%0.22B-34.8%
2021-03-310.05B-7.8%-40.9%0.26B-26.1%
2020-12-310.06B-5.5%-18.5%0.30B-11.8%
2020-09-300.06B-33.5%-34.8%0.31B-5.3%
2020-06-300.09B+1.9%-10.6%0.34B+18.7%
2020-03-310.09B+27.2%+21.8%0.35B+49.6%
2019-12-310.07B-24.4%+16.2%0.34B+61.3%
2019-09-300.09B-8.8%+73.0%0.33B+38.3%
2019-06-300.10B+38.7%+106.6%0.29B+28.3%
2019-03-310.07B+21.4%+58.2%0.23B+15.5%
2018-12-310.06B+12.6%-31.5%0.21B+16.7%
2018-09-300.05B+9.0%+28.8%0.24B+155.1%
2018-06-300.05B+6.2%+71.1%0.22B+338.6%
2018-03-310.05B-47.4%+120.1%0.20B+806.5%
2017-12-310.09B+111.5%+5588.3%0.18B+11495.0%
2017-09-300.04B+44.8%0.09B
2017-06-300.03B+36.7%0.05B
2017-03-310.02B+1259.3%0.02B
2016-12-310.00B0.00B
2016-09-300.00B0.00B
2016-06-300.00B0.00B
2016-03-310.00B0.00B
2015-12-310.00B0.00B
2015-09-300.00B0.00B
2015-06-300.00B0.00B
2015-03-310.00B0.00B
2014-12-310.00B0.00B
2014-09-300.00B0.00B
2014-06-300.00B0.00B
2014-03-310.00B0.00B
2013-12-310.00B0.00B
2013-09-300.00B0.00B
2013-06-300.00B0.00B
2013-03-310.00B0.00B
2012-12-310.00B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20250.24B+47.5%
20240.16B-17.7%
20230.19B-33.5%
20220.29B+38.2%
20210.21B-28.2%
20200.29B-12.0%
20190.34B+61.3%
20180.21B+16.7%
20170.18B+11495.0%
20160.00B
20150.00B
20140.00B
20130.00B
20120.00B